Heidelberg, Germany

Matthias Bozza

This inventor holds 1 USPTO granted patent and 4 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: Deutsches Krebsforschungszentrum. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthias Bozza. Retrieved from https://idiyas.com/inventor/matthias-bozza

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Matthias Bozza: Innovator in Genetic Modification

Introduction

Matthias Bozza is a notable inventor based in Heidelberg, Germany. He has made significant contributions to the field of genetic engineering, particularly through his innovative patent related to DNA vectors. His work has implications for medical applications, especially in treating genetic diseases.

Latest Patents

Matthias Bozza holds a patent for "Non-integrating DNA vectors for the genetic modification of cells." This invention involves a polynucleotide that comprises at least one promoter and an S/MAR element. The S/MAR element is strategically located downstream of the promoter in the 3' UTR of the transcription unit. Additionally, the S/MAR element is flanked by a 5′ splice donor site and a 3′ splice acceptor site. The invention also includes a composition comprising the polynucleotide, which is intended for use in medicine and for treating genetic diseases.

Career Highlights

Throughout his career, Matthias Bozza has worked with prominent organizations, including the Deutsches Krebsforschungszentrum and Nature Technology Corporation. His experience in these institutions has allowed him to develop and refine his innovative ideas in genetic modification.

Collaborations

Matthias Bozza has collaborated with Richard Harbottle, a fellow researcher in the field. Their partnership has contributed to advancements in genetic engineering and the development of new therapeutic approaches.

Conclusion

Matthias Bozza's work in genetic modification showcases his innovative spirit and dedication to advancing medical science. His patent on non-integrating DNA vectors represents a significant step forward in the treatment of genetic diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…